Advancing Neonatal Screening for Pyridoxine-Dependent Epilepsy-ALDH7A1 Through Combined Analysis of 2-OPP, 6-Oxo-Pipecolate and Pipecolate in a Butylated FIA-MS/MS Workflow. [PDF]
Donge M +20 more
europepmc +1 more source
Structural analysis of pathogenic mutations targeting Glu427 of ALDH7A1, the hot spot residue of pyridoxine-dependent epilepsy. [PDF]
Laciak AR +3 more
europepmc +1 more source
Structural and biochemical consequences of pyridoxine-dependent epilepsy mutations that target the aldehyde binding site of aldehyde dehydrogenase ALDH7A1. [PDF]
Laciak AR +4 more
europepmc +1 more source
Disrupted de novo pyrimidine biosynthesis impairs adult hippocampal neurogenesis and cognition in pyridoxine-dependent epilepsy. [PDF]
Yan J, Wu J, Xu M, Wang M, Guo W.
europepmc +1 more source
Drug-Resistant Epilepsy or Pyridoxine-Dependent Epilepsy: A Dilemma
Surekha Dabla, Neeraj Kumar
openaire +1 more source
Simultaneous quantification of alpha-aminoadipic semialdehyde, piperideine-6-carboxylate, pipecolic acid and alpha-aminoadipic acid in pyridoxine-dependent epilepsy. [PDF]
Xue J +11 more
europepmc +1 more source
Metabolic Outputs of the Gut Microbiome: Implications for Epilepsy. [PDF]
Gallucci A +3 more
europepmc +1 more source
Novel mutations in pyridoxine-dependent epilepsy
Pyridoxine-Dependent Epilepsy (PDE) is a rare autosomal recessive disease with neonatal seizures resistant to conventional anti-epileptic drugs. This metabolic disease has to be diagnosed early and treated to improve outcome. We report on two new mutations that open new prenatal prospects and suggest a new diagnostic procedure.We describe PDE in a ...
Sophie Hamelin, G S Salomons
exaly +8 more sources

